Hidden homeowner costs climb to nearly $16,000 a year, Eli Lilly approaches trillion-dollar status amid weight-loss drug ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...

In the last five years, LLY has drawn 23 outlier inflow signals and is up 387.5%. The blue bars below show when LLY was a top ...

Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...

These drugs promise faster results with fewer side effects, and in some cases, reversal or slows the disease progression.

The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...

Novo Nordisk goes "on the offensive" following Trump deal that also included rival Eli Lilly, putting an exclamation point on rapidly declining GLP-1 drug prices. Experts say the unusual situation ...

Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...

Eli Lilly shares rose again Tuesday, their sixth increase in the past seven sessions. The drugmaker's market cap also closed ...

Tuesday, November 18, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft ...

Mazur, GM of LillyDirect, breaks down the platform’s new partnership with Walmart and its implications for the pharma ...

Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump ...